ReviewOncoTargets and therapy2022

Aberrant MAPK Signaling Offers Therapeutic Potential for Treatment of Ovarian Carcinoma.

Eva Colic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.